TRP_1170x120_3-8-19

Sandoz One Source

Sandoz launches Zarxio, the nation’s first biosimilar

Sandoz launches Zarxio, the nation’s first biosimilar

NEW YORK — Sandoz has inaugurated a new era in medicine with the release of Zarxio, the first biosimilar of a biologic drug approved in the United States. The Novartis subsidiary said Thursday that Zarxio — a biosimilar of Amgen Corp.’s oncology drug Neupogen, which boosts white blood cells — would broaden access to an